Prospective, Observational Study of Low-risk Criteria for Node Metastasis in Endometrial Cancer
NCT ID: NCT01527396
Last Updated: 2015-10-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
529 participants
OBSERVATIONAL
2011-12-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
3 Year Recurrence Free Survival in Ultra-low-risk Endometrial Cancer
NCT04227249
Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.
NCT02598219
Lymph Node Counts in Endometrial Cancer Staging
NCT02335775
Predictors of Para-aortic Lymph Node Metastasis of Cervical Cancer
NCT05717751
Implementation of Surgical Safety and Intraoperative Metastasis Identification Through Deep Learning: Multicentric Video Collection for Minimally Invasive Sentinel Lymph Node Dissection in Uterine Malignancies
NCT06619002
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with a preoperative magnetic resonance imaging (MRI) and serum CA-125 within 4 weeks from surgical staging.
* Patients who underwent adequate systemic lymph node dissection during surgical staging.
Exclusion Criteria
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Korean Gynecologic Oncology Group
OTHER
National Cancer Center, Korea
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sokbom Kang
Director, Gynecologic Oncology Research Div.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sokbom Kang
Role: STUDY_CHAIR
National Cancer Center, Korea
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Korean Gynecologic Oncology Group
Seoul, Kangnam-gu, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KGOG2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.